Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mediators Inflamm ; 2016: 7174127, 2016.
Article in English | MEDLINE | ID: mdl-27403038

ABSTRACT

Aims. Repetitive brief ischemia and reperfusion (I/R) is associated with left ventricular dysfunction during development of ischemic cardiomyopathy. We investigated the role of zinc-donor proteins metallothionein MT1 and MT2 in a closed-chest murine model of I/R. Methods. Daily 15-minute LAD-occlusion was performed for 1, 3, and 7 days in SV129 (WT)- and MT1/2 knockout (MT(-/-))-mice (n = 8-10/group). Hearts were examined with M-mode echocardiography and processed for histological and mRNA studies. Results. Expression of MT1/2 mRNA was transiently induced during repetitive I/R in WT-mice, accompanied by a transient inflammation, leading to interstitial fibrosis with left ventricular dysfunction without infarction. In contrast, MT(-/-)-hearts presented with enhanced apoptosis and small infarctions leading to impaired global and regional pump function. Molecular analysis revealed maladaptation of myosin heavy chain isoforms and antioxidative enzymes in MT1/2(-/-)-hearts. Despite their postponed chemokine induction we found a higher total neutrophil density and macrophage infiltration in small infarctions in MT(-/-)-hearts. Subsequently, higher expression of osteopontin 1 and tenascin C was associated with increased myofibroblast density resulting in predominately nonreversible fibrosis and adverse remodeling in MT1/2(-/-)-hearts. Conclusion. Cardioprotective effects of MT1/2 seem to be exerted via modulation of contractile elements, antioxidative enzymes, inflammatory response, and myocardial remodeling.


Subject(s)
Cardiomyopathies/metabolism , Metallothionein/metabolism , Myocardial Infarction/immunology , Myocardial Infarction/metabolism , Myocardial Ischemia/metabolism , Myocardial Reperfusion Injury/metabolism , Animals , Apoptosis/genetics , Apoptosis/physiology , Cardiomyopathies/genetics , Cardiomyopathies/immunology , Disease Models, Animal , Echocardiography , Metallothionein/genetics , Mice , Mice, Knockout , Myocardial Infarction/genetics , Myocardial Ischemia/immunology , Myocardial Reperfusion Injury/genetics , Myocardial Reperfusion Injury/immunology , Osteopontin/metabolism , Tenascin/metabolism
2.
Biomed Res Int ; 2014: 124063, 2014.
Article in English | MEDLINE | ID: mdl-24971311

ABSTRACT

Repetitive brief ischemia and reperfusion (I/R) is associated with ventricular dysfunction in pathogenesis of murine ischemic cardiomyopathy and human hibernating myocardium. We investigated the role of matricellular protein osteopontin-1 (OPN) in murine model of repetitive I/R. One 15-min LAD-occlusion followed by reperfusion was performed daily over 3, 5, and 7 consecutive days in C57/Bl6 wildtype- (WT-) and OPN(-/-)-mice (n = 8/group). After echocardiography hearts were processed for histological and mRNA-studies. Cardiac fibroblasts were isolated, cultured, and stimulated with TGF- ß 1. WT-mice showed an early, strong, and cardiomyocyte-specific osteopontin-expression leading to interstitial macrophage infiltration and consecutive fibrosis after 7 days I/R in absence of myocardial infarction. In contrast, OPN(-/-)-mice showed small, nontransmural infarctions after 3 days I/R associated with significantly worse ventricular dysfunction. OPN(-/-)-mice had different expression of myocardial contractile elements and antioxidative mediators and a lower expression of chemokines during I/R. OPN(-/-)-mice showed predominant collagen deposition in macrophage-rich small infarctions. We found lower induction of tenascin-C, MMP-9, MMP-12, and TIMP-1, whereas MMP-13-expression was higher in OPN(-/-)-mice. Cultured OPN(-/-)-myofibroblasts confirmed these findings. In conclusion, osteopontin seems to modulate expression of contractile elements, antioxidative mediators, and inflammatory response and subsequently remodel in order to protect cardiomyocytes in murine ischemic cardiomyopathy.


Subject(s)
Matrix Metalloproteinases/metabolism , Myocardial Infarction/physiopathology , Myocardial Ischemia/physiopathology , Myocardial Reperfusion Injury/physiopathology , Osteopontin/metabolism , Tenascin/metabolism , Animals , Cardiomyopathies/physiopathology , Collagen/metabolism , Disease Models, Animal , Fibroblasts/metabolism , Fibrosis/physiopathology , Humans , Male , Mice , Mice, Inbred C57BL , Myocardial Infarction/metabolism , Myocardial Ischemia/metabolism , Myocardial Reperfusion Injury/metabolism , Myocytes, Cardiac/metabolism
3.
Arch Gynecol Obstet ; 285(1): 93-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21773786

ABSTRACT

In this report, we describe a patient who developed severe headache following epidural analgesia for labor and delivery. Although the epidural puncture had been reported to be uneventful, headache was initially suspected to result from an accidental dural puncture. After the headache worsened, a sinus venous thrombosis was suspected and subsequently confirmed by magnetic resonance imaging. This case highlights the difficulty of differential diagnosis of headache in the postnatal period in patients after EDA and stresses the necessity of considering alternative pathologies.


Subject(s)
Post-Dural Puncture Headache/diagnosis , Postpartum Period , Puerperal Disorders/diagnosis , Venous Thrombosis/diagnosis , Adult , Analgesia, Epidural/adverse effects , Analgesics/therapeutic use , Anticoagulants/therapeutic use , Diagnosis, Differential , Female , Fibrinolytic Agents/therapeutic use , Heparin/therapeutic use , Humans , Magnetic Resonance Imaging , Post-Dural Puncture Headache/drug therapy , Pregnancy , Puerperal Disorders/drug therapy , Severity of Illness Index , Treatment Outcome , Venous Thrombosis/drug therapy , Warfarin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...